Leveling up: Treating Uptake as Endogenous May Increase the Value of Screening Programs.

IF 3.1 3区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Medical Decision Making Pub Date : 2025-04-01 Epub Date: 2025-02-24 DOI:10.1177/0272989X251319794
Jose A Robles-Zurita, Neil Hawkins, Janet Bouttell
{"title":"Leveling up: Treating Uptake as Endogenous May Increase the Value of Screening Programs.","authors":"Jose A Robles-Zurita, Neil Hawkins, Janet Bouttell","doi":"10.1177/0272989X251319794","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundWe aimed to illustrate that health economists should consider individual heterogeneity when solving the problem of finding the optimal combination of sensitivity and specificity that maximizes the average health utility of a target population in a screening program.MethodsA theoretical framework compares the solution under standard economics of diagnoses to the optimal combination under an endogenous uptake analysis, where screening participation is given by heterogenous health preferences. An applied example used calibrated parameters with real data from the bowel cancer screening program in the United Kingdom. Scenario analyses show how the results would change with parameter values, if disease risk and health utilities were not independent and if screening uptake were not completely determined by health preferences.ResultsA general theoretical result states that the endogenous uptake analysis leads to a weakly higher true- and false-positive rate than would be optimal under the standard approach. In the same way, the endogenous solution would lead to a lower uptake rate. The base-case scenario of the applied example illustrates that a screening program using the endogenous solution would generate 21.1% more quality-adjusted life-years than when using the standard solution. The scenario analyses show when the endogenous analysis is most valued and that the general result applies for a wide range of situations when theoretical assumptions are relaxed.LimitationsThe results obtained are valid under the assumptions made. Analysts should evaluate if those could hold in the applied screening context.ConclusionsIndividual heterogeneity and uptake decisions are relevant factors to consider in the problem of finding an optimal combination of sensitivity and specificity for a screening test.HighlightsThe value of screening programs can be higher if heterogeneity of preferences in the target population is considered.The optimal operation of a screening test depends on health utilities of the target population and on the heterogeneity of these health utilities.Under heterogeneity of health utilities, the optimal operation of a screening test does not maximize screening uptake.A general theoretical result states that the endogenous uptake analysis leads to a weakly higher true- and false-positive rate than would be optimal under a standard approach; this is true for a wide range of situations.</p>","PeriodicalId":49839,"journal":{"name":"Medical Decision Making","volume":" ","pages":"318-331"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Decision Making","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/0272989X251319794","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundWe aimed to illustrate that health economists should consider individual heterogeneity when solving the problem of finding the optimal combination of sensitivity and specificity that maximizes the average health utility of a target population in a screening program.MethodsA theoretical framework compares the solution under standard economics of diagnoses to the optimal combination under an endogenous uptake analysis, where screening participation is given by heterogenous health preferences. An applied example used calibrated parameters with real data from the bowel cancer screening program in the United Kingdom. Scenario analyses show how the results would change with parameter values, if disease risk and health utilities were not independent and if screening uptake were not completely determined by health preferences.ResultsA general theoretical result states that the endogenous uptake analysis leads to a weakly higher true- and false-positive rate than would be optimal under the standard approach. In the same way, the endogenous solution would lead to a lower uptake rate. The base-case scenario of the applied example illustrates that a screening program using the endogenous solution would generate 21.1% more quality-adjusted life-years than when using the standard solution. The scenario analyses show when the endogenous analysis is most valued and that the general result applies for a wide range of situations when theoretical assumptions are relaxed.LimitationsThe results obtained are valid under the assumptions made. Analysts should evaluate if those could hold in the applied screening context.ConclusionsIndividual heterogeneity and uptake decisions are relevant factors to consider in the problem of finding an optimal combination of sensitivity and specificity for a screening test.HighlightsThe value of screening programs can be higher if heterogeneity of preferences in the target population is considered.The optimal operation of a screening test depends on health utilities of the target population and on the heterogeneity of these health utilities.Under heterogeneity of health utilities, the optimal operation of a screening test does not maximize screening uptake.A general theoretical result states that the endogenous uptake analysis leads to a weakly higher true- and false-positive rate than would be optimal under a standard approach; this is true for a wide range of situations.

升级:将摄取视为内源性可能会增加筛选程序的价值。
背景:我们的目的是说明卫生经济学家在解决筛选项目中寻找灵敏度和特异性的最佳组合以最大化目标人群的平均健康效用的问题时应考虑个体异质性。方法:一个理论框架将标准诊断经济学下的解决方案与内源性摄取分析下的最佳组合进行比较,内源性摄取分析下的筛查参与是由异质健康偏好给出的。一个应用实例使用校准参数和来自英国肠癌筛查项目的真实数据。情景分析表明,如果疾病风险和健康效用不是独立的,如果筛查的接受程度不是完全由健康偏好决定,结果将如何随参数值而变化。结果:一个一般的理论结果表明,内源性摄取分析导致的真阳性率和假阳性率略高于标准方法下的最佳结果。同样,内源性溶液也会导致较低的吸收速率。应用示例的基本情况说明,使用内生溶液的筛选程序比使用标准溶液的筛选程序多产生21.1%的质量调整寿命年。情景分析显示了什么时候最重视内生分析,并且一般结果适用于放宽理论假设的各种情况。局限性:所得结果在假设条件下是有效的。分析师应该评估这些是否适用于应用筛选环境。结论:个体异质性和摄取决定是寻找筛选试验敏感性和特异性最佳组合的相关因素。重点:如果考虑到目标人群偏好的异质性,筛查项目的价值可能更高。筛选试验的最佳操作取决于目标人群的健康效用和这些健康效用的异质性。在医疗服务的异质性下,筛查试验的最佳操作并不能最大限度地提高筛查的吸收率。一般的理论结果表明,内源性摄取分析导致的真阳性率和假阳性率略高于标准方法下的最佳率;在很多情况下都是如此。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Decision Making
Medical Decision Making 医学-卫生保健
CiteScore
6.50
自引率
5.60%
发文量
146
审稿时长
6-12 weeks
期刊介绍: Medical Decision Making offers rigorous and systematic approaches to decision making that are designed to improve the health and clinical care of individuals and to assist with health care policy development. Using the fundamentals of decision analysis and theory, economic evaluation, and evidence based quality assessment, Medical Decision Making presents both theoretical and practical statistical and modeling techniques and methods from a variety of disciplines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信